Detalles de la búsqueda
1.
A phase II single institution single arm prospective study with paclitaxel, ifosfamide and cisplatin (TIP) as first-line chemotherapy in high-risk germ cell tumor patients with more than ten years follow-up and retrospective correlation with ERCC1, Topoisomerase 1, 2A, p53 and HER-2 expression.
J BUON
; 21(3): 698-708, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27569093
Resultados
1 -
1
de 1
1
Próxima >
>>